An 1 -year-old boy presented with enteric fever (titres for Salmonella typhi positive as TH 640 and TO 320). He Clinical examination revealed an alert young boy with normal vital signs. Bilateral papilloedema was observed, with left lateral rectus paralysis. There were no other focal neurologic deficits. Visual acuity was normal with bilateral concentric constriction of visual fields and enlargement of blind spots. Electroencephalogram (EEG) showed diffuse theta to delta slowing. A computed tomography (CT) scan ofthe head was normal. Spinal tap showed an opening pressure of 300 mm cerebrospinal fluid (CSF) with normal cytology, sugar and proteins.
The patient was a 26-year-old woman who presented with an infection of the urinary tract (significant growth ofEscherichia coli on culture). She was prescribed norfloxacin (400 mg bid) for 14 days with ibuprofen (400 mg) and paracetamol (325 mg) eight hourly for an initial four days, until fever and dysuria subsided. After one week of therapy she complained of severe occipitonuchal headache with vomiting and visual obscurations, along with restlessness and tremulousness. There was no history of ear discharge or intake of oral contraceptives.
Clinical examination revealed an anxious, thinly built woman with coarse action tremors. Vital signs were normal. The patient showed bilateral gross papilloedema with paradiscal haemorrhages and retinal edema. There were no focal neurologic deficits. Visual acuity was normal with peripheral constriction offields and enlarged blind spots on perimetry. EEG was normal. CT scan of the head showed no mass lesion but lateral ventricles were small and chinked. Spinal tap revealed an opening pressure of 350 mm CSF with normal cytology, sugar and proteins.
Norfloxacin was discontinued. Acetazolamide (500 mg eight hourly) and alprazolam were prescribed. This led to relief of symptoms with regression of papilloedema in nine weeks. Mild tremors, claimed to be present since childhood, persisted. Criteria for causative factors of symptomatic intracranial hypertension * at least two cases have been described * the individual case satisfies the diagnostic criteria for idiopathic intracranial hypertension * head trauma and conditions that result in intracranial sinovenous thrombosis and hyperviscosity syndrome have been excluded
is so common among women of child-bearing years that provocation ofintracranial hypertension by them appears to be a chance association.4 Quinolones had not until now been identified as causative agents of intracranial hypertension. They are structural analogues of nalidixic acid with improved pharmacologic properties (increased potency, broad antibacterial spectrum, and ability to attain high concentration in most body tissues and fluids).5 The most active representatives of this group include ciprofloxacin, ofloxacin, pefloxacin, norfloxacin, and enoxacin. Although all the quinolones have a common basic structure of carboxylic acid, they belong chemically to different groups, which explains their different pharmacokinetics. A major proportion of pefloxacin is transformed metabolically to norfloxacin. 6 The association of intracranial hypertension with quinolone therapy may well be related to their structural analogy with nalidixic acid.
The rise in intracranial pressure in patients on nalidixic acid therapy is mostly acute and has been reported in 1-3% of patients receiving it.'-' Focal neurologic signs, drowsiness, seizures, or abnormal EEG have been described in these patients and in this respect they differ from those with idiopathic intracranial hypertension which occurs predominantly in obese woman ofreproductive age with a history of recent weight gain and menstrual irregularity. 3 The exact pathophysiology of intracranial hypertension in patients on nalidixic acid is not clear. It appears to be an unpredictable and idiosyncratic response to the drug. Induction of cortical venous thrombosis, metabolic acidosis or altered CSF dynamics have been blamed but lack corroborative evidence.7'9 Whether the symptomatic intracranial hypertension found in our patients is an idiosyncratic reaction or a dose-related phenomenon is difficult to surmise. The elucidation of the cause and effect relationship of quinolones in such patients remains highly desirable.
Final diagnosis Symptomatic intracranial hypertension, possibly associated with quinolones.
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